ADPT

Adaptive Biotechnologies Corp · USD

Market closed US (NYSE / Nasdaq) · 09:30–16:00 · Mon 17:10 · approx

Deep AI analysis (big model)

No deep analysis yet. Portfolio holdings are analysed automatically; for any other stock, click “Request deep AI analysis” above.

About Adaptive Biotechnologies Corp

Adaptive Biotechnologies Corp is a biotechnology company focused on developing novel immunotherapies for cancer and other diseases by leveraging its proprietary adaptive immune screening platform.

HealthcareTechnologyBiotechnology

Ticker	ADPT
Name	Adaptive Biotechnologies Corp
Currency	USD
Sector	Healthcare

Reputation

😎

How liked 50/100

From 0 recent analysed stories — 0 good · 0 bad · 0 neutral. Trend: stable.

Reputation builds as news about this company is analysed.

Price history & forecast

30-day forecast — Linear regression, Holt's exponential smoothing, and drift, plus a news-adjusted consensus (sentiment tilt +0.00). Estimates only, not advice.

Candlestick, volume & news sentiment

…

good bad neutral closed

Open/high/low/close candles with volume beneath; hover for OHLC, change and volume. Dots mark analysed news by sentiment; shaded bands are when the market was closed. Day and Week show intraday detail; Month+ show daily candles. Step through time with ‹ ›.

Forecast accuracy (backtested)

No scored forecasts yet. Every visit records the day's forecast; once those predicted dates pass, this table fills in with how each method actually did (1 snapshot(s) recorded so far, none matured yet).

Technical analysis

NEUTRAL

70.94

RSI (14)i

15.65

SMA 20i

14.62

SMA 50i

15.40

SMA 200i

-0.65%

1di

-3.66%

1wi

30.16%

1mi

4.20%

30d voli

20.46

52w highi

10.14

52w lowi

-18.38%

from highi

0.79

MACDi

Downtrend (50d below 200d)Overbought (RSI 71)MACD bullish crossover

Computed from 258 locally-stored price bars.

AI signals

HOLD 70% · long_term 2026-06-08 10:15

The stock has experienced a strong upward move over the past week, with significant gains in recent days. However, there are no recent news or events to support this trend continuation. The lack of new information makes it difficult to predict whether this is a sustainable uptrend or if the stock might correct. Given the current price action and the absence of supporting news, I recommend holding the stock rather than taking on additional risk.

qwen2.5:3b